Get the Stockscreener App
0.5197
11.67%
0.0543
After Hours:
.50
-0.0197
-3.79%
Moleculin Biotech Inc stock is traded at $0.5197, with a volume of 23.16M.
It is up +11.67% in the last 24 hours and up +12.56% over the past month.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
See More
Previous Close:
$0.4654
Open:
$0.454
24h Volume:
23.16M
Relative Volume:
6.04
Market Cap:
$25.72M
Revenue:
-
Net Income/Loss:
$-29.77M
P/E Ratio:
-0.034
EPS:
-15.2954
Net Cash Flow:
$-24.23M
1W Performance:
+4.80%
1M Performance:
+12.56%
6M Performance:
-49.54%
1Y Performance:
-78.79%
1-Day Range:
$0.4427
$0.63
1-Week Range:
$0.43
$0.63
52-Week Range:
$0.25
$3.6499
Moleculin Biotech Inc Stock (MBRX) Company Profile
Name
Moleculin Biotech Inc
Sector
Industry
Phone
713-300-5160
Address
5300 MEMORIAL DRIVE, HOUSTON, TX
Compare MBRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBRX
Moleculin Biotech Inc
|
0.5197 | 23.04M | 0 | -29.77M | -24.23M | -15.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Moleculin Biotech Inc Stock (MBRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-09-25 | Resumed | H.C. Wainwright | Buy |
| Feb-12-25 | Downgrade | Maxim Group | Buy → Hold |
| Jul-18-22 | Resumed | Oppenheimer | Outperform |
Moleculin Biotech Inc Stock (MBRX) Latest News
Can Moleculin Biotech Inc. stock continue upward trend2025 Technical Patterns & Precise Buy Zone Identification - newser.com
Can machine learning forecast Moleculin Biotech Inc. recovery2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
Can Moleculin Biotech Inc. stock deliver surprise earnings beatJuly 2025 Breakouts & AI Enhanced Trade Execution Alerts - newser.com
How sentiment analysis helps forecast Moleculin Biotech Inc.July 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Market reaction to Moleculin Biotech Inc.’s recent newsInsider Buying & Comprehensive Market Scan Insights - newser.com
Is it time to cut losses on Moleculin Biotech Inc.Insider Buying & Technical Confirmation Trade Alerts - newser.com
Will Moleculin Biotech Inc. (MOL) stock top growth indexes2025 Trading Volume Trends & Fast Moving Market Watchlists - newser.com
Real time scanner hits for Moleculin Biotech Inc. explained2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - newser.com
Relative strength of Moleculin Biotech Inc. in sector analysisTrade Ideas & AI Optimized Trading Strategy Guides - newser.com
Is Moleculin Biotech Inc. stock attractive after correctionTrade Risk Assessment & Smart Allocation Stock Tips - newser.com
How Moleculin Biotech Inc. stock benefits from global expansion2025 Dividend Review & Community Driven Trade Alerts - newser.com
Why Moleculin Biotech Inc. stock is rated strong buy2025 Earnings Surprises & Trade Opportunity Analysis Reports - newser.com
Can Moleculin Biotech Inc. (MOL) stock stage a strong rebound this quarter2025 Market Trends & Weekly High Return Stock Forecasts - newser.com
Why analysts maintain buy rating on Moleculin Biotech Inc. (MOL) stockWeekly Stock Analysis & Free Safe Capital Growth Stock Tips - newser.com
Will Moleculin Biotech Inc. continue its uptrendMarket Activity Recap & Free Daily Entry Point Trade Alerts - newser.com
Published on: 2025-11-02 06:40:39 - newser.com
What margin trends mean for Moleculin Biotech Inc. stockTrade Risk Assessment & Growth Focused Entry Point Reports - newser.com
How Moleculin Biotech Inc. stock reacts to inflationary pressuresStock Surge & Expert Curated Trade Setups - newser.com
Published on: 2025-11-02 01:09:40 - newser.com
Is Moleculin Biotech Inc. meeting your algorithmic filter criteria2025 Momentum Check & Smart Money Movement Tracker - newser.com
How to use a screener to detect Moleculin Biotech Inc. breakoutsJuly 2025 Big Picture & Risk Managed Investment Entry Signals - newser.com
Predicting Moleculin Biotech Inc. trend using moving averages2025 Investor Takeaways & Daily Technical Stock Forecast Reports - newser.com
Will Moleculin Biotech Inc. stock go up soonJuly 2025 Spike Watch & High Yield Stock Recommendations - newser.com
Moleculin Biotech Inc Stock (MBRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):